Search

everythinglearnresearchcommunity

for

Search:↓

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Women with AGA have higher lipid levels, increasing heart disease risk.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

A man's gray hair got darker and thicker after using a psoriasis drug.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

A 65-year-old woman has a growing bald spot on her scalp.